My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}

Want to join the conversation?

$BDX {{ '2016-05-05T20:45:54+0000' | timeago}} • Webcast

Leerink Partners analyst Richard Newitter questions about the opportunity to get upgrades with the product cycle. President of Life Science Segment Linda Tharby said that in the liquid cytology business in US, $BDX is seeing a flattening of the business. Outside the US, the company is seeing strong double-digit performance.

User RC xNair {{ '2016-10-27T13:31:32+0000' | timeago}}

Of all the Wall St firms out there, Goldman Sachs $GS is the most revered for the way they're run - hiring the best, highly competitive, a closely-knit peer group and making tons of profits for the shareholders. An interesting interview of its CEO Llyod Blankfein by Carlyle groups chief David Rubenstein

User Ramesh Raju {{ '2016-10-27T10:38:07+0000' | timeago}}

Deutsche Bank posts Q3 net profit of 278 million euros.

User Vishnu Beri {{ '2016-10-27T01:52:28+0000' | timeago}}

Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.

User Michael Michael {{ '2016-10-26T23:46:35+0000' | timeago}}

Watching $TSLA Oct 28th $215 Calls for possible entry

User RC xNair {{ '2016-10-26T18:36:03+0000' | timeago}}

Chipotle stock is crashing like a falling knife after it's earnings report last evening; down about 10% already today! Was Bill Ackman wrong in buying about 10% stake in $CMG couple of months ago? Or is this market reacting to disappointing earnings? And can they really get customers to trust them again after food-safety crisis?

$IP {{ '2016-10-27T14:41:39+0000' | timeago}} • Webcast

$IP expects volume to be lower in 4Q16 due to four less shipping days in the North American corrugated packaging business. This is expected to negatively impact North American packaging business results by about $50MM. The company expects seasonally stronger volume in the Brazil papers business and seasonal demand improvement in EMEA packaging.

$CELG {{ '2016-10-27T14:31:58+0000' | timeago}} • Infographic

$CELG Celgene Corp. Earnings AlphaGraph: Q3 2016 Highlights.

$TMO {{ '2016-10-27T14:25:52+0000' | timeago}} • Announcement

$TMO's Life Sciences Solutions Segment revenue grew 14% to $1.23Bil in 3Q16. Analytical Instruments Segment revenue grew 15% to $898MM. Specialty Diagnostics Segment revenue increased 3% to $800MM. Laboratory Products and Services Segment revenue grew 7% to $1.75Bil.

$DOW {{ '2016-10-27T14:24:56+0000' | timeago}} • Webcast

$DOW said its drivers for Ag segment performance was that about a third was due to the higher volumes and higher prices. The other third came from continued improvement on self help, productivity and cost cutting. And finally, the driver was the turnaround in currency.

$IP {{ '2016-10-27T14:24:53+0000' | timeago}} • Webcast

The BoD of $IP approved a 5% increase to the annual dividend during 3Q16, moving it to $1.85 per share.  The company also continues to work towards being prepared to close the acquisition of the Weyerhaeuser pulp business in 4Q16. $IP received approvals from the European Union and Brazil with regards to the transaction.